Development of a Gut Microbiome Based Prognostic Signature Predicting Risk of Hepatocellular Cancer Recurrence After Ablative Therapies

Grant

Awarded By

Total Award Amount

  • 1960080.00

    • Direct Costs

  • 1319920.00

    • Sponsor Award Id

  • W81XWH2110649

    • Contributor

  • Casey Morrow Ph.D.   Investigator  
  • Jayme Locke   Investigator  
  • Robert Cannon   Investigator  
  • Vikas Dudeja   Principal Investigator